249 related articles for article (PubMed ID: 37240204)
1. Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma.
Gelmi MC; Verdijk RM; Houtzagers LE; van der Velden PA; Kroes WGM; Luyten GPM; Vu THK; Jager MJ
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240204
[TBL] [Abstract][Full Text] [Related]
2. MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance.
Gelmi MC; Houtzagers LE; Strub T; Krossa I; Jager MJ
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682684
[TBL] [Abstract][Full Text] [Related]
3. The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
Lu S; Slominski A; Yang SE; Sheehan C; Ross J; Carlson JA
J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):26-40. PubMed ID: 20482673
[TBL] [Abstract][Full Text] [Related]
4. MITF deficiency accelerates GNAQ-driven uveal melanoma.
Phelps GB; Hagen HR; Amsterdam A; Lees JA
Proc Natl Acad Sci U S A; 2022 May; 119(19):e2107006119. PubMed ID: 35512098
[TBL] [Abstract][Full Text] [Related]
5. Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1.
Gelmi MC; Wierenga APA; Kroes WGM; van Duinen SG; Karuntu JS; Marinkovic M; Bleeker JC; Luyten GPM; Vu THK; Verdijk RM; Jager MJ
Ophthalmol Sci; 2023 Sep; 3(3):100297. PubMed ID: 37193315
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 3 and 8q Aberrations in Uveal Melanoma Show Greater Impact on Survival in Patients with Light Iris versus Dark Iris Color.
Wierenga APA; Brouwer NJ; Gelmi MC; Verdijk RM; Stern MH; Bas Z; Malkani K; van Duinen SG; Ganguly A; Kroes WGM; Marinkovic M; Luyten GPM; Shields CL; Jager MJ
Ophthalmology; 2022 Apr; 129(4):421-430. PubMed ID: 34780841
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of melanogenesis pathway and its association with the ultrastructural characterisation of melanosomes in uveal melanoma.
Jha J; Singh MK; Singh L; Pushker N; Meel R; Lomi N; Bakhshi S; Nag TC; Chosdol K; Sen S; Kashyap S
Br J Ophthalmol; 2023 Sep; ():. PubMed ID: 37734767
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
9. [Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor].
Denat L; Larue L
Bull Cancer; 2007 Jan; 94(1):81-92. PubMed ID: 17237008
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
11. The roles of microphthalmia-associated transcription factor and pigmentation in melanoma.
Hsiao JJ; Fisher DE
Arch Biochem Biophys; 2014 Dec; 563():28-34. PubMed ID: 25111671
[TBL] [Abstract][Full Text] [Related]
12. MITF reprograms the extracellular matrix and focal adhesion in melanoma.
Dilshat R; Fock V; Kenny C; Gerritsen I; Lasseur RMJ; Travnickova J; Eichhoff OM; Cerny P; Möller K; Sigurbjörnsdóttir S; Kirty K; Einarsdottir BÓ; Cheng PF; Levesque M; Cornell RA; Patton EE; Larue L; de Tayrac M; Magnúsdóttir E; Ögmundsdóttir MH; Steingrimsson E
Elife; 2021 Jan; 10():. PubMed ID: 33438577
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
14. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
[TBL] [Abstract][Full Text] [Related]
15. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.
Yan D; Dong XD; Chen X; Yao S; Wang L; Wang J; Wang C; Hu DN; Qu J; Tu L
PLoS One; 2012; 7(7):e40967. PubMed ID: 22848417
[TBL] [Abstract][Full Text] [Related]
16. MITF deficiency and oncogenic GNAQ each promote proliferation programs in zebrafish melanocyte lineage cells.
Phelps GB; Amsterdam A; Hagen HR; García NZ; Lees JA
Pigment Cell Melanoma Res; 2022 Sep; 35(5):539-547. PubMed ID: 35869673
[TBL] [Abstract][Full Text] [Related]
17. Microphthalmia transcription factor analysis in posterior uveal melanomas.
Mouriaux F; Vincent S; Kherrouche Z; Maurage CA; Planque N; Monté D; Labalette P; Saule S
Exp Eye Res; 2003 Jun; 76(6):653-61. PubMed ID: 12742347
[TBL] [Abstract][Full Text] [Related]
18. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
[TBL] [Abstract][Full Text] [Related]
19. Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation.
Vachtenheim J; Ondrušová L
Exp Dermatol; 2015 Jul; 24(7):481-4. PubMed ID: 25866058
[TBL] [Abstract][Full Text] [Related]
20. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
Naffouje S; Naffouje R; Bhagwandin S; Salti GI
Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
